Wu R - Search Results

1

Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.

Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH. Tashiro H, et al. Among authors: wu r. Cancer Res. 1997 Sep 15;57(18):3935-40. Cancer Res. 1997. PMID: 9307275

2

Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR. Greenspan DL, et al. Among authors: wu r. Cancer Res. 1997 Nov 1;57(21):4692-8. Cancer Res. 1997. PMID: 9354423

3

Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.

Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM. Szych C, et al. Among authors: wu r. Am J Pathol. 1999 Jun;154(6):1849-55. doi: 10.1016/S0002-9440(10)65442-9. Am J Pathol. 1999. PMID: 10362811 Free PMC article.

4

Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.

Wu R, Connolly DC, Dunn RL, Cho KR. Wu R, et al. J Natl Cancer Inst. 2000 Feb 16;92(4):338-44. doi: 10.1093/jnci/92.4.338. J Natl Cancer Inst. 2000. PMID: 10675384

5

Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.

Wu R, Connolly DC, Ren X, Fearon ER, Cho KR. Wu R, et al. Neoplasia. 1999 Oct;1(4):311-4. doi: 10.1038/sj.neo.7900042. Neoplasia. 1999. PMID: 10935485 Free PMC article.

6

Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.

Connolly DC, Greenspan DL, Wu R, Ren X, Dunn RL, Shah KV, Jones RW, Bosch FX, Muñoz N, Cho KR. Connolly DC, et al. Among authors: wu r. Clin Cancer Res. 2000 Sep;6(9):3505-10. Clin Cancer Res. 2000. PMID: 10999736

7

Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix.

Wu R, Connolly D, Ngelangel C, Bosch FX, Muñoz N, Cho KR. Wu R, et al. Oncogene. 2000 Nov 16;19(48):5543-6. doi: 10.1038/sj.onc.1203934. Oncogene. 2000. PMID: 11114733

8

Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.

Wu R, Zhai Y, Fearon ER, Cho KR. Wu R, et al. Cancer Res. 2001 Nov 15;61(22):8247-55. Cancer Res. 2001. PMID: 11719457

9

Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas.

Zhai Y, Wu R, Schwartz DR, Darrah D, Reed H, Kolligs FT, Nieman MT, Fearon ER, Cho KR. Zhai Y, et al. Among authors: wu r. Am J Pathol. 2002 Apr;160(4):1229-38. doi: 10.1016/s0002-9440(10)62550-3. Am J Pathol. 2002. PMID: 11943708 Free PMC article.

10

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR. Schwartz DR, et al. Among authors: wu r. Cancer Res. 2002 Aug 15;62(16):4722-9. Cancer Res. 2002. PMID: 12183431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,900 results

Search Page

Filters